Latest Breaking News On - Regenerative therapies - Page 5 : comparemela.com

Regenerative Therapies Market: Rising demand for stem cell and tissue-cell research methods to drive the market

The use of certain kinds of cells or cell products for sick organs or tissues is known as regenerative therapy.

Global Drug Delivery Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021

Orthopedic Biomaterials Market to reach US$ 21.3 Bn by 2027 Due to Use of Orthopedic Biomaterials in Stem Cell-based Regenerative Medicines, Projects TMR Study

Transparency Market Research: Orthopedic Biomaterials Market to reach US$ 21.3 Bn by 2027 Due to Use of Orthopedic Biomaterials in Stem Cell-based Regenerative Medicines, Projects TMR Study

Study identifies drug with a positive effect on heart failure patients with preserved ejection fraction

Until now, patients with heart failure with preserved ejection fraction – the most common type of heart failure in the elderly – have had no access to evidenced-based treatments. For the first time, a large clinical trial led by Prof. Dr. Stefan Anker from Charité – Universitätsmedizin Berlin has identified a drug which has a distinctly positive effect on prognosis. In patients affected by this type of heart failure, the drug – empagliflozin – reduces the risk of hospitalization or cardiovascular death by 21 percent. The results of this research have been published in the New England Journal of Medicine.